Extending life after lung transplantation – Defining the structural and immunological drivers of chronic lung allograft dysfunction

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1144826

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Lung Transplantation (LTx) saves life. However, chronic rejection limits survival after LTx compared to other solid organ transplants. Chronic rejection develops when the LTx recipient produces antibodies against the donor lung. With a team of global leaders in the field we will dissect the antibody response to LTx. By better understanding the immune drivers of antibody-mediated rejection, we aim to reduce the incidence of chronic rejection thereby improving survival after LTx.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $739,190.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Humoural Immunology and Immunochemistry

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

B cells | humoral immunology | lung transplantation | microarray analysis | natural killer cells

Related Links